These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 11766333

  • 1. [Experimental systems in CML biology].
    Maru Y.
    Nihon Rinsho; 2001 Dec; 59(12):2322-8. PubMed ID: 11766333
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 4. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M, Pisa P, O'Brien S, Kurzrock R, Siciliano M, Cork A, Andersson BS, Kohli V, Kantarjian H.
    Cancer Res; 1993 Aug 01; 53(15):3603-10. PubMed ID: 8339266
    [Abstract] [Full Text] [Related]

  • 5. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
    McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C, Collins N, O'Reilly RJ.
    Bone Marrow Transplant; 1998 Aug 01; 22(4):367-74. PubMed ID: 9722072
    [Abstract] [Full Text] [Related]

  • 6. Blast crisis in a murine model of chronic myelogenous leukemia.
    Daley GQ, Van Etten RA, Baltimore D.
    Proc Natl Acad Sci U S A; 1991 Dec 15; 88(24):11335-8. PubMed ID: 1763047
    [Abstract] [Full Text] [Related]

  • 7. The biology of chronic myelogenous leukemia:mouse models and cell adhesion.
    Wertheim JA, Miller JP, Xu L, He Y, Pear WS.
    Oncogene; 2002 Dec 09; 21(56):8612-28. PubMed ID: 12476308
    [Abstract] [Full Text] [Related]

  • 8. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 09; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
    Becher R, Kloke O.
    Verh Dtsch Ges Pathol; 1990 Mar 09; 74():36-42. PubMed ID: 1708614
    [Abstract] [Full Text] [Related]

  • 11. Model mice for BCR/ABL-positive leukemias.
    Honda H, Hirai H.
    Blood Cells Mol Dis; 2001 Mar 09; 27(1):265-78. PubMed ID: 11358387
    [Abstract] [Full Text] [Related]

  • 12. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV, Gerasimova LP, Sarkisian GP, Borovkova TV, Dukhovenskaia EA, Manakova TE, Naĭdenova NM, Timofeev AM, Grineva NI.
    Tsitologiia; 2007 Mar 09; 49(10):889-900. PubMed ID: 18074781
    [Abstract] [Full Text] [Related]

  • 13. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
    Verstegen MM, Cornelissen JJ, Terpstra W, Wagemaker G, Wognum AW.
    Leukemia; 1999 Apr 09; 13(4):618-28. PubMed ID: 10214871
    [Abstract] [Full Text] [Related]

  • 14. Differences between normal and CML stem cells: potential targets for clinical exploitation.
    Eaves AC, Barnett MJ, Ponchio L, Cashman JD, Petzer AL, Eaves CJ.
    Stem Cells; 1998 Apr 09; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
    [Abstract] [Full Text] [Related]

  • 15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL, Megat Baharuddin PJ, Chin LP, Zakaria Z, Yegappan S, Sathar J, Tan SM, Purushothaman V, Chang KM.
    Cancer Genet Cytogenet; 2008 Jan 01; 180(1):60-4. PubMed ID: 18068536
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
    Kuroda J, Kimura S, Andreeff M, Ashihara E, Kamitsuji Y, Yokota A, Kawata E, Takeuchi M, Tanaka R, Murotani Y, Matsumoto Y, Tanaka H, Strasser A, Taniwaki M, Maekawa T.
    Br J Haematol; 2008 Jan 01; 140(2):181-90. PubMed ID: 18028486
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Propagation of human blastic myeloid leukemias in the SCID mouse.
    Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON.
    Blood; 1992 Apr 15; 79(8):2089-98. PubMed ID: 1562735
    [Abstract] [Full Text] [Related]

  • 20. Allosterically controllable maxizyme-mediated suppression of progression of leukemia in mice.
    Kuwabara T, Tanabe T, Warashina M, Xiong KX, Tani K, Taira K, Asano S.
    Biomacromolecules; 2001 Apr 15; 2(4):1220-8. PubMed ID: 11777396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.